We're very concerned about small and medium-sized businesses. We know they're the backbone of the economy and they want to have products for Canadians that are safe and effective. That's why we have fee mitigation for those small businesses, such as decreases of 25% to 50% in costs for small companies, and if it's their first submission there would be a complete fee waiver.
The proposals out there are for consultation, really. We have had, as Dr. Lourenco said, thousands of comments. We're in the process of looking at those and making modifications. We'll put forward a new proposal, but it comes down to the fact that there are improvements that need to be made. Those improvements require some resources, so the question is, where do those resources come from?
Really, this is the only health product line where 100% of the costs for the regulatory framework are from appropriations, from taxpayer dollars.